BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Overview Fund Activity
Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

67 hedge funds and large institutions have $229M invested in Bellicum Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
-11
Holders Change %
-14.1%
% of All Funds
1.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
33
Reduced
15
Closed
16
Calls
$346K
Puts
$532K
Net Calls
-$186K
Net Calls Change
+$363K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$31M
2
BFA
BlackRock Fund Advisors
California
$11.4M
3
First Eagle Investment Management
First Eagle Investment Management
New York
$11.1M
4
State Street
State Street
Massachusetts
$3.68M
5
KCM
Kennedy Capital Management
Missouri
$4.23M

Top Sellers

1
CAM
Cormorant Asset Management
Massachusetts
$0
2
Millennium Management
Millennium Management
New York
$0
3
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$30.5M
4
SM
Sabby Management
Florida
$0
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
DekaBank Deutsche Girozentrale
76
DekaBank Deutsche Girozentrale
Germany
– -$123K -1,400 Closed
ERIM
77
Eagle Ridge Investment Management
Connecticut
– -$127K -1,355 Closed
EMG
78
Ellington Management Group
Connecticut
– -$120K -1,280 Closed
Jane Street
79
Jane Street
New York
– -$117K -1,256 Closed
TRCT
80
Tower Research Capital (TRC)
New York
– -$16K -174 Closed
CLOS
81
Compagnie Lombard Odier SCmA
Switzerland
– -$9K -100 Closed
PAM
82
Panagora Asset Management
Massachusetts
– -$9K -91 Closed
1 2 3
4